公开(公告)号：US12097324B2

公开(公告)日：2024-09-24

申请号：US15563097

申请日：2016-03-31

申请人： Fisher & Paykel Healthcare Limited

发明人： Samantha Dale Oldfield ,  Milanjot Singh Assi ,  Dexter Chi Lun Cheung ,  Callum James Thomas Spence ,  Alicia Jerram Hunter Evans ,  Craig Karl White ,  Matthew Jon Payton ,  Thomas Heinrich Barnes

IPC分类号： A61M16/00 ,  A61B1/267 ,  A61M11/00 ,  A61M16/04 ,  A61M16/06 ,  A61M16/08 ,  A61M16/10 ,  A61M16/12 ,  A61M16/16 ,  A61M16/20

CPC分类号： A61M16/022 ,  A61B1/267 ,  A61M11/007 ,  A61M16/0003 ,  A61M16/0066 ,  A61M16/04 ,  A61M16/0493 ,  A61M16/0666 ,  A61M16/0672 ,  A61M16/0677 ,  A61M16/0875 ,  A61M16/1005 ,  A61M16/104 ,  A61M16/12 ,  A61M16/16 ,  A61M16/201 ,  A61M16/202 ,  A61M16/204 ,  A61M2016/0018 ,  A61M2016/0021 ,  A61M2016/0027 ,  A61M2016/003 ,  A61M16/0434 ,  A61M16/0461 ,  A61M16/0688 ,  A61M2016/1025 ,  A61M2016/1035 ,  A61M2202/0208 ,  A61M2202/0241 ,  A61M2202/025 ,  A61M2202/0275 ,  A61M2202/0283 ,  A61M2202/03 ,  A61M2202/0488 ,  A61M2205/05 ,  A61M2205/18 ,  A61M2205/3303 ,  A61M2205/3334 ,  A61M2205/50 ,  A61M2230/205 ,  A61M2230/432 ,  A61M2230/60 ,  A61M2230/65 ,  A61M2230/65 ,  A61M2230/005 ,  A61M2230/205 ,  A61M2230/005 ,  A61M2230/432 ,  A61M2230/005 ,  A61M2230/60 ,  A61M2230/005

摘要： This invention relates to, among other embodiments, methods and apparatus/systems for controlling gases delivery to a patient, such as via a patient interface. Such methods comprising receiving an input relating to either a patient's breathing phase and/or another patient parameter, controlling a flow of gases to be delivered to the patient and the inclusion in said flow of gases of a supplementary gas, wherein the amount of supplementary gas provided to the patient is substantially synchronized with respect to the patient's breathing phase and/or another patient parameter.

公开(公告)号：US12089954B2

公开(公告)日：2024-09-17

申请号：US17289866

申请日：2019-11-18

申请人： BIOTRONIK AG

发明人： Bodo Quint

IPC分类号： A61B5/00 ,  A61B5/0538 ,  A61B5/06 ,  A61B5/25 ,  A61F2/958 ,  A61M25/10

CPC分类号： A61B5/6853 ,  A61B5/0538 ,  A61B5/068 ,  A61B5/25 ,  A61B5/6886 ,  A61F2/958 ,  A61M25/10184 ,  A61B2562/0209 ,  A61F2250/001 ,  A61M2205/3303 ,  A61M2205/3317 ,  A61M2205/332 ,  A61M2205/3327 ,  A61M2205/3344 ,  A61M2230/65

摘要： A balloon catheter system has a balloon extending in an axial direction and surrounding a balloon interior. The balloon has an outer side facing away from the balloon interior. A catheter is connected to the balloon and extending in the axial direction, the catheter having a lumen in fluid communication with the balloon interior. First and second annular electrodes are disposed on the outer side, each extending in a circumferential direction of the balloon and being located opposite one another in the axial direction. The electrodes are configured to measure one of more of strain of the balloon in the circumferential direction, strain of the balloon in the radial direction, an impedance of tissue of a patient resting against the electrodes, and a redox potential of tissue of the patient contacting at least one of the electrodes.

公开(公告)号：US12053606B2

公开(公告)日：2024-08-06

申请号：US17007086

申请日：2020-08-31

申请人： Celero Systems, Inc.

发明人： Benjamin D. Pless ,  Daniel Bacher

IPC分类号： A61M31/00 ,  A61K9/00 ,  A61K9/48 ,  A61K31/485 ,  A61P25/36

CPC分类号： A61M31/00 ,  A61K9/0065 ,  A61K9/4808 ,  A61K31/485 ,  A61P25/36 ,  A61M2205/18 ,  A61M2205/3303 ,  A61M2205/3306 ,  A61M2205/3523 ,  A61M2205/3553 ,  A61M2205/50 ,  A61M2205/52 ,  A61M2210/1042 ,  A61M2230/04 ,  A61M2230/06 ,  A61M2230/20 ,  A61M2230/30 ,  A61M2230/42 ,  A61M2230/50 ,  A61M2230/63 ,  A61M2230/65

摘要： An opioid overdose rescue device is provided that includes an ingestible capsule. Within the ingestible capsule is a non-refillable drug dispenser comprising an opioid antidote and at least one sensor configured to detect at least one physiological parameter indicative of an opioid overdose. A controller is also contained within the ingestible capsule and is operatively coupled to the drug dispenser and the least one sensor. The controller is configured to receive a signal detected by the least one sensor of the at least one physiological parameter to actuate release of the opioid antidote from the drug dispenser into the intestine of the patient upon a determination that the at least one physiological parameter falls outside a threshold value or range for the at least one physiological parameter indicating that an opioid overdose has been detected.

公开(公告)号：US20240198019A1

公开(公告)日：2024-06-20

申请号：US18180824

申请日：2023-03-08

申请人： Yun-Shan CHANG ,  Da-Wei LIN

发明人： Yun-Shan CHANG ,  Da-Wei LIN

IPC分类号： A61M15/00

CPC分类号： A61M15/0001 ,  A61M2205/13 ,  A61M2205/3592 ,  A61M2205/8206 ,  A61M2230/005 ,  A61M2230/65

摘要： The present invention is an active vaporization suction system and a controlling method thereof. The system includes a medication device and an active suction device. The medication device is detachably mounted on the active suction device. When a suction module is suctioned, a flow module outputs a launching signal to a control module. The control module outputs a vaporization current control signal to a power supply module according to the launching signal. The power supply module generates and outputs a Joule vaporization current to a Joule vaporizer of the medication device according to the vaporization current control signal, so that the Joule vaporizer vaporizes a liquefied medication in a vaporization chamber into a vapor medication. In this way, when the user actively sucks the suction module, the user can take the vapor medication for medical treatment, which increases an absorption rate of the vapor medication.

公开(公告)号：US20240123180A1

公开(公告)日：2024-04-18

申请号：US18149702

申请日：2023-01-04

申请人： Sweetie Stewart

发明人： Sweetie Stewart

IPC分类号： A61M21/02

CPC分类号： A61M21/02 ,  A61M2021/0027 ,  A61M2230/04 ,  A61M2230/65

摘要： The present invention relates to a wearable smartwatch system for detecting negative emotions of a wearer of the smartwatch of the system. The system includes an earbud coupled to the smartwatch using a Bluetooth connection. More specifically, the smartwatch includes a plurality of electrodes for measuring HRV and electrodermal activity of the wearer. A processor of the smartwatch processes the data measured by the electrodes to determine emotional state of the wearer. A pre-recorded audio is automatically played out through the earbud to help calm down the wearer upon determination of the negative emotional state. In some embodiments, an alert signal is sent to a parent, teacher, or other caregiver to obtain assistance for a wearer to cope with negative emotions and feelings.

公开(公告)号：US20240081427A1

公开(公告)日：2024-03-14

申请号：US18510363

申请日：2023-11-15

申请人： RAI Strategic Holdings, Inc.

发明人： Nathan Andrew Terry ,  Noah Mark Minskoff

IPC分类号： A24F40/60 ,  A24F40/42 ,  A61M11/04 ,  A61M15/00 ,  A61M15/06

CPC分类号： A24F40/60 ,  A24F40/42 ,  A61M11/041 ,  A61M11/042 ,  A61M15/0001 ,  A61M15/0025 ,  A61M15/0035 ,  A61M15/06 ,  A24F40/10 ,  A61M2205/0205 ,  A61M2205/0233 ,  A61M2205/13 ,  A61M2205/3592 ,  A61M2205/52 ,  A61M2205/59 ,  A61M2205/8206 ,  A61M2230/005 ,  A61M2230/65

摘要： A personal vapor inhaling unit is disclosed. An electronic flameless vapor inhaler unit that may simulate a cigarette has a cavity that receives a cartridge in the distal end of the inhaler unit. The cartridge brings a substance to be vaporized in contact with a wick. When the unit is activated, and the user provides suction, the substance to be vaporized is drawn out of the cartridge, through the wick, and is atomized by the wick into a cavity containing a heating element. The heating element vaporizes the atomized substance. The vapors then continue to be pulled by the user through a mouthpiece and mouthpiece cover where they may be inhaled.

公开(公告)号：US11918795B2

公开(公告)日：2024-03-05

申请号：US16855840

申请日：2020-04-22

申请人： Bard Access Systems, Inc.

发明人： Shayne Messerly

IPC分类号： A61M5/32 ,  A61M25/06

CPC分类号： A61M5/3287 ,  A61M25/0693 ,  A61M2205/3313 ,  A61M2205/52 ,  A61M2230/205 ,  A61M2230/30 ,  A61M2230/65

摘要： Disclosed herein are puncturing devices and puncturing systems including the puncturing devices. Such puncturing devices and systems include those that sense a difference between venous blood and arterial blood as a function of blood oxygen, impedance, or pressure. As a result, the puncturing devices and systems are able to differentiate between a venipuncture and an arterial puncture. Methods of the puncturing devices and systems for differentiating between a venipuncture and an arterial puncture for are also disclosed.

公开(公告)号：US11904113B2

公开(公告)日：2024-02-20

申请号：US17077793

申请日：2020-10-22

申请人： Roivios Limited

发明人： David E. Orr ,  Jacob L. Upperco ,  John R. Erbey, II

IPC分类号： A61M25/04 ,  A61M25/01 ,  A61M25/00 ,  A61M25/10 ,  A61M1/00 ,  A61M39/12 ,  A61M25/02

CPC分类号： A61M25/04 ,  A61M1/73 ,  A61M1/74 ,  A61M1/743 ,  A61M1/75 ,  A61M1/80 ,  A61M1/84 ,  A61M25/007 ,  A61M25/0017 ,  A61M25/0023 ,  A61M25/0026 ,  A61M25/0041 ,  A61M25/0108 ,  A61M25/1025 ,  A61M25/10 ,  A61M39/12 ,  A61M2025/0213 ,  A61M2202/0496 ,  A61M2205/3303 ,  A61M2205/3317 ,  A61M2205/3334 ,  A61M2205/3368 ,  A61M2205/52 ,  A61M2205/583 ,  A61M2210/1082 ,  A61M2210/1085 ,  A61M2210/1089 ,  A61M2230/00 ,  A61M2230/207 ,  A61M2230/50 ,  A61M2230/65

摘要： A ureteral catheter is provided, including a drainage lumen including a proximal portion and a distal portion configured to be positioned in a patient's kidney, renal pelvis, and/or in the ureter adjacent to the renal pelvis, the distal portion including a retention portion for maintaining positioning of the distal portion of the drainage lumen, the retention portion including at least two openings on a sidewall of the retention portion for permitting fluid flow into the drainage lumen wherein a total area of a proximal most opening of the at least two openings is less than a total area of more distal opening(s) nearer to the distal end of the drainage lumen, and wherein when negative pressure is applied through the ureteral catheter, fluid is drawn into the ureteral catheter through the at least two openings.

公开(公告)号：US20240008763A1

公开(公告)日：2024-01-11

申请号：US18472625

申请日：2023-09-22

申请人： TheraNova, LLC

发明人： Daniel R. BURNETT

IPC分类号： A61B5/06 ,  A61M1/28 ,  A61M5/142 ,  A61M5/172 ,  A61B5/20 ,  A61F7/12 ,  A61F7/00 ,  A61B5/00 ,  A61B5/0205

CPC分类号： A61B5/068 ,  A61M1/28 ,  A61M5/142 ,  A61M5/1723 ,  A61B5/208 ,  A61F7/12 ,  A61F7/0085 ,  A61B5/0022 ,  A61B5/02055 ,  A61B5/207 ,  A61M2230/04 ,  A61M2230/10 ,  A61M2230/202 ,  A61M2230/205 ,  A61M2230/208 ,  A61M2230/65 ,  A61M2025/0166

摘要： An automated therapy system having an infusion catheter; a sensor adapted to sense a patient parameter; and a controller communicating with the sensor and programmed to control flow output from the infusion catheter into a patient based on the patient parameter without removing fluid from the patient. The invention also includes a method of controlling infusion of a fluid to a patient. The method includes the following steps: monitoring a patient parameter with a sensor to generate a sensor signal; providing the sensor signal to a controller; and adjusting fluid flow to the patient based on the sensor signal without removing fluid from the patient.

公开(公告)号：US20230372657A1

公开(公告)日：2023-11-23

申请号：US18362059

申请日：2023-07-31

申请人： Jeff Majdali

发明人： Jeff Majdali

IPC分类号： A61M16/06 ,  A61M16/00

CPC分类号： A61M16/0672 ,  A61M16/024 ,  A61M2016/0039 ,  A61M2205/3334 ,  A61M2205/502 ,  A61M2205/583 ,  A61M2230/65

摘要： Methods and apparatus for administering oxygen therapy, and particularly high-flow oxygen therapy is disclosed herein. A respiratory monitoring system may non-invasively determine greatest or average peak inspiratory flow rate of a patient based on biofeedback response received from the patient. Medical air, oxygen, or a combination of both may be delivered to the patient at a flow rate equal to greater than the determined greatest or average peak inspiratory flow rate of the patient to meet or exceed inspiratory demand of the patient. Fraction of oxygen inspired by the patient may be determined based on the greatest or average peak inspiratory flow rate and may be adjusted through high-flow oxygen therapy meeting inspiratory demand to prevent entrainment of ambient air or through low-flow oxygen therapy by accounting for entrainment of ambient air based on the greatest or average peak inspiratory flow rate to address medical needs of the patient.